Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 36.04
+1.50 (4.34%)
Aug 11, 2026, 1:14 PM HKT
HKG:3692 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 15,028 | 15,028 | 12,261 | 10,104 | 9,382 | 9,935 |
Revenue Growth | 13.95% | 22.57% | 21.35% | 7.69% | -5.56% | 14.32% |
Gross Profit Gross Profit Growth | 13,509 | 13,509 | 11,144 | 9,071 | 8,512 | 9,065 |
Operating Income Operating Income Growth | 5,401 | 5,401 | 3,902 | 2,679 | 2,607 | 2,821 |
Net Income Net Income Growth | 5,555 | 5,555 | 4,372 | 3,278 | 2,584 | 2,713 |
Earnings Per Share EPS Growth | 0.93 | 0.93 | 0.73 | 0.52 | 0.44 | 0.44 |
EPS Growth | 15.69% | 26.42% | 40.62% | 19.65% | -1.29% | 1.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 31,575 | 31,575 | 23,419 | 24,884 | 21,631 | 18,941 |
Total Debt Total Debt Growth | 105.09 | 105.09 | 117.89 | 4,304 | 4,378 | 3,828 |
Net Cash (Debt) Net Cash Growth | 31,469 | 31,469 | 23,301 | 20,580 | 17,253 | 15,114 |
Net Cash Growth | 16.53% | 35.05% | 13.22% | 19.29% | 14.15% | 10.86% |
Net Cash Per Share Net Cash Per Share Growth | 5.26 | 5.26 | 3.92 | 3.42 | 2.91 | 2.52 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,738 | 6,738 | 3,862 | 3,116 | 2,741 | 2,577 |
Capital Expenditures CapEx Growth | -356.43 | -356.43 | -221.96 | -219.6 | -272.82 | -460.03 |
Free Cash Flow Free Cash Flow Growth | 6,382 | 6,382 | 3,640 | 2,897 | 2,468 | 2,117 |
Free Cash Flow Growth | 42.07% | 75.31% | 25.67% | 17.36% | 16.60% | 119.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 89.89% | 89.89% | 90.89% | 89.78% | 90.72% | 91.24% |
Operating Margin | 35.94% | 35.94% | 31.83% | 26.52% | 27.79% | 28.39% |
Pretax Margin | 43.59% | 43.59% | 41.48% | 37.27% | 31.43% | 33.22% |
Profit Margin | 36.97% | 36.97% | 35.66% | 32.44% | 27.54% | 27.31% |
FCF Margin | 42.47% | 42.47% | 29.69% | 28.67% | 26.31% | 21.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.432 | 0.388 | 0.316 | 0.193 | 0.088 | 0.073 |
Dividend Per Share Growth | -45.49% | 22.73% | 63.53% | 118.47% | 20.84% | 12.44% |
Dividend Yield | 1.31% | 1.20% | 1.98% | 1.40% | 0.71% | 0.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.41 | 35.33 | 22.04 | 25.86 | 30.08 | 33.79 |
Forward PE | 30.21 | 36.29 | 24.05 | 28.31 | 24.97 | 27.09 |
P/FCF Ratio | 29.49 | 30.76 | 26.47 | 29.25 | 31.49 | 43.30 |
PS Ratio | 12.52 | 13.06 | 7.86 | 8.39 | 8.28 | 9.23 |